SAKAR — Sakar Healthcare Share Price
0.000.00%
Last trade - 00:00- IN₹7.01bn
- IN₹7.80bn
- IN₹1.53bn
- 60
- 17
- 33
- 25
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.67 | ||
| Price to Tang. Book | 2.69 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.51 | ||
| EV to EBITDA | 19.48 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.51% | ||
| Return on Equity | 5.16% | ||
| Operating Margin | 13.79% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 829.8 | 947.39 | 1,282.27 | 1,333.59 | 1,533.52 | n/a | n/a | 17.58% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +30.56 | +10.16 | +40.57 | -32.23 | -15.76 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sakar Healthcare Limited is an India-based pharmaceutical formulations company. The Company is engaged in manufacturing of pharmaceutical products providing liquid orals, cephalosporin tablet, capsule, dry powder syrup, dry powder injections, liquid injectable (SVP) in ampoules, vials & lyophilized injections, oral solid dosages and research & development of above products. The Company's oncology products include oral solid dosage (tablet & capsule), liquid injection, lyophilized injection, active pharmaceutical ingredient (API), CDMO products and CRAMs. The Company's product portfolio includes approximately 175 formulations for the international markets, 292 registered brands under its own name in more than 24 therapeutic areas. It has a presence across the regions of Africa (Anglo & Francophone), SEASIA, CIS, Latin & Central America and in Europe. The Company has set up a research-driven vertically integrated with API for oncology formulation manufacturing unit.
Directors
- Sanjay Shah CHM (62)
- Jhonny Kudilil CFO
- Bharat Soni CCO
- Aarsh Shah MDR (30)
- Rita Shah EDR (57)
- Shailesh Patel NID
- Hemendrakumar Shah NID (69)
- Prashant Srivastav NID
- Last Annual
- March 31st, 2024
- Last Interim
- June 30th, 2024
- Incorporated
- March 26th, 2004
- Public Since
- October 14th, 2016
- No. of Shareholders
- 7,556
- No. of Employees
- 325
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 21,749,910
- Address
- 406,Silver Oaks Comm. Complex,, AHMEDABAD, 380007
- Web
- http://www.sakarhealthcare.com/
- Phone
- +91 7926584655
- Contact
- Bharat Soni
- Auditors
- J.S. Shah & Co.
Upcoming Events for SAKAR
Q2 2025 Sakar Healthcare Ltd Earnings Release
Q3 2025 Sakar Healthcare Ltd Earnings Release
Similar to SAKAR
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Sakar Healthcare share price?
As of Today at 23:02 UTC, shares in Sakar Healthcare are trading at IN₹322.35. This share price information is delayed by 15 minutes.
How has the Sakar Healthcare share price performed this year?
Shares in Sakar Healthcare last closed at IN₹322.35 and the price had moved by -8.48% over the past 365 days. In terms of relative price strength the Sakar Healthcare share price has underperformed the S&P BSE 100 Index by -28.94% over the past year.
What are the analyst and broker recommendations for Sakar Healthcare?
There is no consensus recommendation for this security.
Find out moreWhat is the Sakar Healthcare dividend yield?
Sakar Healthcare does not currently pay a dividend.
Does Sakar Healthcare pay a dividend?
Sakar Healthcare does not currently pay a dividend.
When does Sakar Healthcare next pay dividends?
Sakar Healthcare does not currently pay a dividend.
How do I buy Sakar Healthcare shares?
To buy shares in Sakar Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Sakar Healthcare?
As of the previous close price of IN₹322.35, shares in Sakar Healthcare had a market capitalisation of IN₹7.01bn.
Where are Sakar Healthcare shares listed?
Here are the trading details for Sakar Healthcare:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: SAKAR
What kind of share is Sakar Healthcare?
Based on an overall assessment of its quality, value and momentum Sakar Healthcare is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Sakar Healthcare share price forecast for 2024?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Sakar Healthcare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sakar Healthcare. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -18.05%.
As of the last closing price of IN₹322.35, shares in Sakar Healthcare were trading -10.49% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Sakar Healthcare PE Ratio?
The Sakar Healthcare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹322.35.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Sakar Healthcare?
Sakar Healthcare's management team is headed by:
- Sanjay Shah - CHM
- Jhonny Kudilil - CFO
- Bharat Soni - CCO
- Aarsh Shah - MDR
- Rita Shah - EDR
- Shailesh Patel - NID
- Hemendrakumar Shah - NID
- Prashant Srivastav - NID